Recalls

Rising Pharma Holdings, Inc is initiating a voluntary recall at the consumer level for Cetirizine Hydrochloride Tablets USP 5 mg, manufactured by Unique Pharmaceutical Laboratories, for Batch Nos. GY825029, GY825030, GY825031 and GY825032, 100's count bottle pack, due to cross contamination with ranitidine. Risk statement: for consumers with a hypersensitivity to the ingredients in ranitidine, there is a reasonable probability that ingestion of cetirizine tablets contaminated with ranitidine could result in serious adverse events including severe hypersensitivity reactions and anaphylaxis. To date, Unique Pharmaceuticals has not received any reports of adverse events related to this recall. Yellowhawk pharmacy has not purchased or dispensed any of the affected lots and patients receiving cetirizine from Yellowhawk pharmacy are not affected by this drug recall.

Major Rugby is voluntarily recalling fifteen varieties of levothyroxine tablets due to out-of-specification results obtained during routine stability testing for assay. This could result in levothyroxine that is subpotent before its expiration date. Yellowhawk pharmacy has not purchased or dispensed any of the affected lots and patients receiving levothyroxine from Yellowhawk pharmacy are not affected by this drug recall.

Trividia Health is updating labeling to ensure users are aware of the updated instruction for the E-5 Error Code in the "Messages" section of the Owner's Booklets. The system displays an E-5 error code for a very high blood glucose event (> 600 mg/dL) or when there is a test strip error.

A voluntary recall by Abbott. Certain sensors may provide inaccurate low glucose readings, which could lead to inappropriate treatment decisions. In rare cases, affected sensors may also pose a battery-related safety risk. Not all sensors are affected — only those from specific lot numbers identified by Abbott.

The FDA published a Class II recall for prazosin hydrochloride manufactured by Teva Pharmaceuticals. The recall affects three dosage strengths and multiple lot numbers that contained potentially cancer-causing chemicals above acceptable safety limits. Yellowhawk pharmacy has not purchased or dispensed any of the affected lots — patients receiving this drug from Yellowhawk pharmacy are not affected.

FDA patient-level recall of duloxetine 20 mg DR capsules manufactured by Breckenridge Pharmaceutical, Inc. Yellowhawk pharmacy has not purchased or dispensed the affected lot (Lot #220128, exp. 12/2024). Patients receiving duloxetine from Yellowhawk pharmacy are not affected.

FDA warning about CVS Health, Leader (Cardinal Health), Rugby (Cardinal Health), Rite Aid, Target Up & Up, Velocity Pharma, and Walmart Equate brands due to potential bacterial contamination. Yellowhawk dispenses Refresh brand artificial tears — patients who received drops from our pharmacy may continue using as directed. Call Yellowhawk Optometry with questions.

Global Pharma Healthcare voluntarily recalled all lots of Artificial Tears Lubricant Eye Drops distributed by EzriCare & Delsam Pharma to the consumer level due to possible contamination. Yellowhawk pharmacy has not purchased nor dispensed any artificial-tear product from this distributor.